News
NOVT
159.52
+0.45%
0.71
Those who invested in Novanta (NASDAQ:NOVT) five years ago are up 221%
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Simply Wall St. · 3d ago
Insider Sell: Novanta
Insider Sell: Novanta
MT Newswires · 11/16 16:41
Should You Sell Novanta (NOVT) Now?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned 3.23%, Advisor Class fund ...
Insider Monkey · 11/14 15:47
Novanta Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
On Friday, Novanta stock earned an upgrade to its Relative Strength (RS) Rating, from 64 to 84. This unique rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major in...
Investor's Business Daily · 11/12 01:36
--Berenberg Bank Adjusts Novanta Price Target to $130 From $132, Maintains Hold Rating
--Berenberg Bank Adjusts Novanta Price Target to $130 From $132, Maintains Hold Rating
MT Newswires · 11/10 09:54
Novanta (NOVT) Surpasses Q3 Earnings and Revenue Estimates
Novanta (NOVT) delivered earnings and revenue surprises of 10.96% and 3.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/08 13:15
Novanta reports Q3 earnings beat; initiates Q4 and raises FY22 guidance
Seekingalpha · 11/08 12:19
Novanta Raises FY22 EPS Outlook To $3.02 - $3.06 From $2.96 to $3.02. Prior, Vs. $3 Estimate
Benzinga · 11/08 12:15
Novanta Q3 Adj. EPS $0.81 Beats $0.74 Estimate, Sales $223.00M Beat $215.38M Estimate
Benzinga · 11/08 12:01
Novanta Announces Financial Results for the Third Quarter 2022
BEDFORD, Mass., November 08, 2022--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2022.
Business Wire · 11/08 11:59
Novanta Logs Higher Q3 Adjusted Earnings, Revenue; Raises 2022 Outlook
Novanta Logs Higher Q3 Adjusted Earnings, Revenue; Raises 2022 Outlook
MT Newswires · 11/08 07:38
-- Earnings Flash (NOVT) NOVANTA Posts Q3 EPS $0.81, vs. Street Est of $0.74
-- Earnings Flash (NOVT) NOVANTA Posts Q3 EPS $0.81, vs. Street Est of $0.74
MT Newswires · 11/08 07:17
-- Earnings Flash (NOVT) NOVANTA Posts Q3 Revenue $223M, vs. Street Est of $215.4M
-- Earnings Flash (NOVT) NOVANTA Posts Q3 Revenue $223M, vs. Street Est of $215.4M
MT Newswires · 11/08 07:14
Is Novanta Inc. (NASDAQ:NOVT) Worth US$136 Based On Its Intrinsic Value?
How far off is Novanta Inc. ( NASDAQ:NOVT ) from its intrinsic value? Using the most recent financial data, we'll take...
Simply Wall St. · 10/26 13:17
Novanta to Present at the Baird 2022 Global Industrial Conference on Wednesday, November 9, 2022
BEDFORD, Mass., October 13, 2022--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckl...
Business Wire · 10/13 21:00
Novanta Inc. (NASDAQ:NOVT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Novanta's (NASDAQ:NOVT) recent performance, when its stock has declined 15...
Simply Wall St. · 10/11 12:53
Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Simply Wall St. · 09/08 14:58
Novanta's Return on Invested Capital Insights
Pulled from Benzinga Pro data, Novanta (NASDAQ:NOVT) showed a loss in earnings since Q1, totaling $17.48 million. Sales, on the other hand, increased by 5.46% to $215.36 million during Q2.
Benzinga · 09/02 14:23
--Berenberg Bank Adjusts Novanta's Price Target to $132 From $120, Maintains Hold Rating
--Berenberg Bank Adjusts Novanta's Price Target to $132 From $120, Maintains Hold Rating
MT Newswires · 08/15 07:23
More
Webull provides a variety of real-time NOVT stock news. You can receive the latest news about Novanta Inc through multiple platforms. This information may help you make smarter investment decisions.
About NOVT
Novanta Inc. is a global supplier of core technology solutions to medical and advanced industrial original equipment manufacturers. It has three segments: Photonics, Vision and Precision Motion. The Photonics segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide (CO2) laser, solid state laser, ultrafast laser and optical light engine products to customers worldwide. The Vision segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies. The Precision Motion segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles to customers worldwide.